Sinopep-Allsino Bio Pharmaceutical ,Ltd. Goodwill

The latest goodwill for 688076.SS is $160M as of June 2026. That compares with $160M in the prior-year period — up 0.0% year over year. Investors often review this figure alongside Sinopep-Allsino Bio Pharmaceutical ,Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 688076.SS's goodwill moved from $160M to $160M — essentially flat versus a year earlier. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Sinopep-Allsino Bio Pharmaceutical ,Ltd.'s operating scale or balance-sheet position.

A goodwill figure of $160M for 688076.SS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 688076.SS's goodwill ($160M), review year-over-year change from $160M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Sinopep-Allsino Bio Pharmaceutical ,Ltd.'s goodwill against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.